Yenson, Vanessa M. http://orcid.org/0000-0002-7112-0785
Amgarth-Duff, Ingrid http://orcid.org/0000-0002-5038-890X
Brown, Linda http://orcid.org/0000-0003-4892-5822
Caperchione, Cristina M. http://orcid.org/0000-0003-2290-5946
Clark, Katherine http://orcid.org/0000-0001-5438-9064
Cross, Andrea
Good, Phillip http://orcid.org/0000-0002-8198-0375
Landers, Amanda http://orcid.org/0000-0002-7385-3739
Luckett, Tim http://orcid.org/0000-0001-6121-5409
Philip, Jennifer http://orcid.org/0000-0002-3312-0645
Steer, Christopher http://orcid.org/0000-0002-7677-3339
Vardy, Janette L. http://orcid.org/0000-0002-5739-5790
Wong, Aaron K. http://orcid.org/0000-0002-6507-1219
Agar, Meera R. http://orcid.org/0000-0002-6756-6119
Funding for this research was provided by:
University of Technology Sydney
Article History
Received: 30 March 2023
Accepted: 15 June 2023
First Online: 3 July 2023
Declarations
:
: The University of Technology Sydney Human Research Ethics Committee approved the study protocol and subsequent survey and meeting rounds (ETH19-4484, ETH21-6079, and ETH21-6558).
: Consent was obtained electronically prior to online surveys: participants were provided the patient information sheet via a hyperlink on the survey landing page and were granted access to the survey once an acknowledgment button was checked. Consent was obtained electronically prior to the consensus building meetings: the patient information sheets were emailed to participants with the link to registration page; successful registration required an acknowledgement button to be checked. Consent via the acknowledgment button was revisited at the start of each consensus meeting.
: CS has received honoraria for advisory board membership from MSD, Merck, Sanofi, Janssen, Ipsen, GSK, and Astra Zeneca. CS has received speaker’s fees from BMS and Novartis. LB, MC, KC, PG, JP, MRA, IAD, AL, JV, AW, and VY have no competing interests.